List of works by Sara Pusceddu

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors.

scientific article

Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study

scientific article

Adjuvant radiotherapy for Merkel cell carcinoma: A systematic review and meta-analysis

scientific article published on 28 February 2019

Are Cyclin-Dependent Kinase 4/6 Inhibitors Without Future in Neuroendocrine Tumors?

scientific article published on 20 May 2020

Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer

scientific article published on 06 September 2007

Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer.

scientific article

Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis

scientific article published on 05 April 2019

Compassionate use of everolimus in a patient with a neuroendocrine tumor: a case report and discussion of the literature.

scientific article published on January 2011

Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study.

scientific article published on 17 November 2017

Diagnosis and management of typical and atypical lung carcinoids

scientific article published on 18 February 2016

Diet and supplements in cancer prevention and treatment: Clinical evidences and future perspectives.

scientific article published on 2 February 2018

Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm

scientific article published on 27 August 2019

Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledge.

scientific article

Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients with Neuroendocrine Tumors: A 5-Year Update

scientific article published on 26 July 2017

Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study

scientific article published on 18 April 2014

Everolimus treatment for neuroendocrine tumors: latest results and clinical potential

scientific article published on 11 January 2017

Everolimus treatment in advanced solid tumors: a personal view

scientific article published on November 2015

Evolution in the treatment of gastroenteropancreatic-neuroendocrine neoplasms, focus on systemic therapeutic options: a systematic review.

scientific article published on July 2015

Fatal case of hepatic portal venous gas following palliative stenting and chemotherapy for occlusive advanced colorectal cancer

From biology to clinical experience: evolution in the knowledge of neuroendocrine tumours

How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies

scientific article

Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors

scientific article published on 20 September 2019

Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)

scientific article published on 07 January 2019

Loss of succinate dehydrogenase subunit B (SDHB) as a prognostic factor in advanced ileal well-differentiated neuroendocrine tumors.

scientific article published on 30 November 2016

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

scientific article published on 13 April 2018

Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes

scientific article published on 18 February 2016

Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms

scientific article published on 09 July 2019

Pancreatic well-differentiated neuroendocrine neoplasms (pWDNENs): what place for everolimus and sunitinib derived from ESMO clinical practice guidelines in the therapeutic algorithm?

scientific article published on 13 March 2013

Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors.

scientific article

Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-Up.

scientific article published on May 2016

Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver.

scientific article

Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors.

scientific article published on 25 May 2017

Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors

scientific article published on 05 June 2017

Rationale and protocol of the MetNET-1 trial, a prospective, single center, phase II study to evaluate the activity and safety of everolimus in combination with octreotide LAR and metformin in patients with advanced pancreatic neuroendocrine tumors.

scientific article published in November 2014

Real-world study of everolimus in advanced progressive neuroendocrine tumors

scientific article

Safety and activity of sorafenib in different histotypes of advanced renal cell carcinoma

scientific article published in January 2007

Safety profile and treatment response of everolimus in different solid tumors: an observational study

scientific article published on January 2014

Somatostatin analogs in association with peptide receptor radionucleotide therapy in advanced well-differentiated NETs

scientific article published on 19 August 2019

Succinate dehydrogenase B subunit immunohistochemical expression predicts aggressiveness in well differentiated neuroendocrine tumors of the ileum

scientific article published on 16 August 2012

Sunitinib and everolimus in pancreatic neuroendocrine tumors

scientific article published on 01 May 2012

Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study

scientific article published on 12 January 2018

Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives

scientific article published on 10 November 2018

The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories

scientific article

The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review.

scientific article published on 14 April 2018

The evolving landscape of criteria for evaluating tumor response in the era of cancer immunotherapy: From Karnofsky to iRECIST

scientific article published on 21 March 2018

The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence

scientific article published on 31 July 2020

Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.

scientific article published in October 2018

Treatment of lung large cell neuroendocrine carcinoma.

scientific article published on 4 March 2016

Update on medical treatment of small intestinal neuroendocrine tumors

scientific article published on 29 June 2016

Well-differentiated neuroendocrine tumor of tailgut cyst. A rare entity with controversial medical opportunities

scientific article

Paulina is supported by:

About Paulina

Help